Recruiting

Lacrifill™

Sponsor:

The Eye Institute of West Florida

Code:

NCT07648095

Conditions

Cataract

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Lacrifill Canalicular Filler

Study Details

Brief summary:

This is a single-site observational study designed to evaluate the efficacy of Lacrifill™ canalicular filler in optimizing ocular surface parameters and biometric precision in prospective cataract surgery patients with dry eye disease (DED).

Conditions

Cataract

Study ID

NCT07648095

Start date

Jul 22, 2026

Status verified date

Aug, 2026

Completion date

Jul 15, 2027

Anticipated

Primary completion date

Jul 15, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age >= 40 years
  • Diagnosed dry eye (OSDI >= 13, TBUT < 10 sec, or Oxford staining >= Grade 2)
  • No recent ocular surgeries (<6 months)
  • No significant changes in DED regimen within last 1 month

Exclusion Criteria:

  • Previous punctal plugs or canalicular cautery
  • Active ocular inflammation or corneal pathology unrelated to DED

Study Design

Enrollment

65 participants

Anticipated

Interventions and Outcome Measures

Arms

Lacrifill Canalicular Filler

Observational Study

Interventions

Lacrifill Canalicular Filler

Lacrifill Canalicular Filler

Primary outcome measure

  • Mean absolute error (MAE) [ Time Frame: 1 month postoperatively ]

Central Contacts and Locations

Central contacts

Renee Bondurant

727-450-4668Renee.Bondurant@eyespecialist.com

Locations

The Eye Institute of West Florida

Recruiting

Largo, Florida, United States, 33770

Contacts

Renee Bondurant

727-450-4668Renee.Bondurant@eyespecialist.com

Principal Investigator:

Neel R Desai, MD

More Information

Sponsor

The Eye Institute of West Florida

Last update posted

Aug 21, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The Eye Institute of West Florida on 2026-08-21.